Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/23/2025

Allergic Rhinitis and Ear Congestion Treatment

Introduction to Treatment

  • Allergic rhinitis can contribute to eustachian tube dysfunction, leading to ear congestion, with the same allergic mediators causing nasal inflammation, eustachian tube edema, and inflammation, resulting in a clogged ear sensation 1
  • The American Academy of Allergy, Asthma, and Immunology recommends second-generation antihistamines, such as fexofenadine, loratadine, and desloratadine, as the preferred treatment for clogged ears potentially caused by allergies, due to their efficacy without sedation at recommended doses 1

Medication Options

  • Second-generation oral antihistamines (e.g., fexofenadine, loratadine, desloratadine) are preferred for treating allergic symptoms without causing sedation, and are more effective for rhinorrhea, sneezing, and itching than for nasal congestion 1
  • First-generation antihistamines (e.g., diphenhydramine, chlorpheniramine, hydroxyzine) can cause significant sedation, performance impairment, and anticholinergic effects, and are not recommended for treatment due to their side effects 1
  • The American Academy of Pediatrics concludes that antihistamines and decongestants are ineffective for otitis media with effusion and are not recommended for treatment 1

Treatment Approach

  • Starting with a second-generation oral antihistamine provides 24-hour relief without sedation, and can be effective for treating allergic rhinitis symptoms 1
  • If there is an inadequate response, adding an intranasal corticosteroid (e.g., fluticasone) can be effective, particularly for nasal congestion, which may help relieve eustachian tube dysfunction 1
  • Antihistamines alone may not fully resolve ear congestion if significant nasal congestion is present, and adding an intranasal corticosteroid is often necessary 1, 2
  • For patients with ongoing allergic rhinitis symptoms despite treatment, adding a leukotriene receptor antagonist (e.g., montelukast) to the existing regimen is recommended, following evidence-based guidelines for allergic rhinitis management when initial therapy is insufficient 3

Special Considerations

  • Avoid AM/PM dosing regimens with first-generation antihistamines, as they can cause daytime drowsiness and performance impairment even when taken only at bedtime 1
  • Special caution is needed for older adults, as first-generation antihistamines increase the risk of falls, cognitive impairment, and anticholinergic effects in elderly patients 1
  • Topical decongestants should be avoided for more than 3 days due to the risk of rhinitis medicamentosa (rebound congestion) 2
  • If asthma is present, treating allergic rhinitis aggressively is particularly important, as it can improve asthma control 4
  • Immunotherapy can modify the disease course rather than just treating symptoms, and can be considered for patients with confirmed allergic triggers and persistent symptoms despite maximal pharmacotherapy 1
  • The combination of an intranasal corticosteroid, oral antihistamine, and LTRA can provide enhanced efficacy for resistant cases, and montelukast can be particularly helpful when allergic rhinitis coexists with asthma 3, 4
  • Intranasal antihistamines may provide more direct relief of nasal symptoms, and can be considered if adding montelukast doesn't provide relief 1
  • Misdiagnosis of allergic rhinitis should be considered if pharmacotherapy continues to fail, with potential non-allergic causes including vasomotor rhinitis, structural problems, or nasal polyps 1